Abraham Avigdor

Spécialisation: Hematologist
35 années d'expérience
Parle:
English, Hebrew
Consultations en ligne : disponibles
Espace de travail: Israël, Ramat Gan, Centre médical Sheba
Directeur de l'Institut d'hématologie ; fondateur et président du groupe de travail israélien sur les lymphomes ; auteur de plus de 130 publications scientifiques.
Le Dr Abraham Avigdor est directeur de l'Institut d'hématologie du centre médical Sheba. Il est une autorité mondiale en matière de lymphome, de thérapie CAR-T et de cancers du sang complexes. Le Dr Avigdor a fondé le groupe de travail israélien sur les lymphomes. Il participe à la direction d'une clinique classée 7e au niveau mondial par Newsweek en 2026.
- Auteur de plus de 130 publications scientifiques sur l'hémato-oncologie et la thérapie cellulaire.
- Pionnier de l'intégration de la thérapie par cellules CAR-T pour le lymphome et le myélome.
- Dirige des programmes de greffe de moelle osseuse allogénique et autologue.
- A été président du groupe d'étude israélien sur les lymphomes.

Consultation en ligne avec Abraham Avigdor

Pratique et facile

100 % sécurisé et confidentiel

$650

Où en sommes-nous ?

1 de 3

Les détails sur ce médecin sont exhaustifs et clairs

Fortement en désaccord

Fortement d’accord

Qualifications

Prof. Abraham Avigdor directs the Institute of Hematology at Sheba Medical Center. He specializes in CAR–T therapy, lymphoma, and hemato-oncology. The specialist founded the Israeli Lymphoma Working Group and serves as its President. He uses his experience to lead programs in bone marrow transplantation and cellular therapies.

Specialization and Hematologic Focus

Dr. Avigdor treats blood cancers and immune system disorders. He specializes in lymphomas, including Hodgkin, Non-Hodgkin, and Burkitt’s lymphoma. The specialist also treats multiple myeloma, acute lymphoblastic leukemia, and various types of anemia. He integrates immunotherapy and targeted biological treatments into his practice.

His therapeutic approach integrates several techniques:

CAR–T Cell Therapy for lymphoma and myeloma
Bone Marrow Transplantation including autologous and allogeneic procedures
Haploidentical Stem Cell Transplantation — a procedure using healthy blood-forming cells from a half-matched donor to replace diseased bone marrow
Precision Diagnostics using PET/CT imaging as a prognostic tool
Immunotherapy and biological targeted regimens
Therapeutic Apheresis and plasma exchange protocols — methods that filter blood to remove harmful substances or abnormal cells

Academic and Clinical Leadership

Dr. Avigdor holds leadership positions at Sheba Medical Center and national bodies. He co-directs the Hematology and Bone Marrow Transplantation Division. Between 2011 and 2018, he served as Chairman of the Israeli Lymphoma Study Group. The specialist currently sits on the National Hematology Consultation Committee for the Health Basket.

Research and Professional Societies

The doctor contributes to medical science through clinical trials and partnerships. He has authored over 130 scientific publications. Dr. Avigdor collaborates with international organizations including:

Lymphoma Study Association (LYSA), France
European Mantle Cell Lymphoma Network (EMCL)
International PET Study Groups in Lymphoma and Myeloma

Work Experience

Director – Institute of Hematology, Sheba Medical Center
Co-Director – Hematology and Bone Marrow Transplant Division, Sheba Medical Center
Senior Lecturer – Tel Aviv University
Former Chairman – Israeli Lymphoma Study Group (2011–2018)
Founder and President – Israeli Lymphoma Working Group

Education and Training

Medical Degree – Ben-Gurion University of the Negev
Residency – Internal Medicine and Hematology, Sheba Medical Center
Postdoctoral Fellowship – Stem Cell Biology, Weizmann Institute of Science

Awards and Recognition

Knesset Prize – for excellence in medical studies
Ministry of Health Award – for outstanding physician performance
Sackler Prize – for research excellence at Tel Aviv University